The therapeutic arena of MM has seen the introduction of new agents in the last decade, including proteasome inhibitors (PIs), immunomodulators (IMiDs), histone deacetylase inhibitors and monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback